title: Endoplasmic reticulum calcium depletion impacts chaperone secretion, innate immunity, and phagocytic uptake of cells.
abstract: A number of immunological functions are ascribed to cell surface-expressed forms of the endoplasmic reticulum (ER) chaperone calreticulin (CRT). In this study, we examined the impact of ER stress-inducing drugs upon cell surface CRT induction and the resulting immunological consequences. We showed that cell surface expression of CRT and secretion of CRT, BiP, gp96, and PDI were induced by thapsigargin (THP) treatment, which depletes ER calcium, but not by tunicamycin treatment, which inhibits protein glycosylation. Surface expression of CRT in viable, THP-treated fibroblasts correlated with their enhanced phagocytic uptake by bone marrow-derived dendritic cells. Incubation of bone marrow-derived dendritic cells with THP-treated fibroblasts enhanced sterile IL-6 production and LPS-induced generation of IL-1β, IL-12, IL-23, and TNF-α. However, extracellular CRT is not required for enhanced proinflammatory responses. Furthermore, the pattern of proinflammatory cytokine induction by THP-treated cells and cell supernatants resembled that induced by THP itself and indicated that other ER chaperones present in supernatants of THP-treated cells also do not contribute to induction of the innate immune response. Thus, secretion of various ER chaperones, including CRT, is induced by ER calcium depletion. CRT, previously suggested as an eat-me signal in dead and dying cellular contexts, can also promote phagocytic uptake of cells subject to ER calcium depletion. Finally, there is a strong synergy between calcium depletion in the ER and sterile IL-6, as well as LPS-dependent IL-1β, IL-12, IL-23, and TNF-α innate responses, findings that have implications for understanding inflammatory diseases that originate in the ER.
authors.affiliation: Graduate Program in Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
authors.forename: Larry Robert
authors.initials: LR
authors.lastname: Peters
authors.forename: Malini
authors.initials: M
authors.lastname: Raghavan
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001854:Bone Marrow Cells / Q000276:immunology / Q000473:pathology; D002118:Calcium / Q000037:antagonists & inhibitors*; D000252:Calcium-Transporting ATPases / Q000037:antagonists & inhibitors / Q000502:physiology; D037282:Calreticulin / Q000172:deficiency / Q000378:metabolism* / Q000502:physiology; D045744:Cell Line, Tumor; D002478:Cells, Cultured; D003713:Dendritic Cells / Q000276:immunology / Q000473:pathology; D005347:Fibroblasts / Q000201:enzymology / Q000276:immunology / Q000473:pathology; D006801:Humans; D007113:Immunity, Innate; D018836:Inflammation Mediators / Q000378:metabolism / Q000502:physiology; D008565:Membrane Proteins / Q000172:deficiency / Q000378:metabolism / Q000502:physiology; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D018832:Molecular Chaperones / Q000378:metabolism* / Q000502:physiology; D008969:Molecular Sequence Data; D010587:Phagocytosis / Q000276:immunology*; D012519:Sarcoplasmic Reticulum / Q000201:enzymology / Q000276:immunology* / Q000378:metabolism*; D019284:Thapsigargin / Q000494:pharmacology
chemical_list: D037282:Calreticulin; D018836:Inflammation Mediators; D008565:Membrane Proteins; D018832:Molecular Chaperones; D019284:Thapsigargin; D000252:Calcium-Transporting ATPases; D002118:Calcium